IMCR logo

Immunocore Holdings plc (IMCR) Cash From Operations

Annual CFO:

$26.06M+$23.12M(+786.43%)
December 31, 2024

Summary

  • As of today, IMCR annual cash from operations is $26.06 million, with the most recent change of +$23.12 million (+786.43%) on December 31, 2024.
  • During the last 3 years, IMCR annual cash from operations has risen by +$169.17 million (+118.21%).
  • IMCR annual cash from operations is now at all-time high.

Performance

IMCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

Quarterly CFO:

-$4.60M-$30.79M(-117.58%)
September 30, 2025

Summary

  • As of today, IMCR quarterly cash from operations is -$4.60 million, with the most recent change of -$30.79 million (-117.58%) on September 30, 2025.
  • Over the past year, IMCR quarterly cash from operations has dropped by -$25.90 million (-121.61%).
  • IMCR quarterly cash from operations is now -117.58% below its all-time high of $26.19 million, reached on June 30, 2025.

Performance

IMCR Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

TTM CFO:

$7.90M-$25.90M(-76.63%)
September 30, 2025

Summary

  • As of today, IMCR TTM cash from operations is $7.90 million, with the most recent change of -$25.90 million (-76.63%) on September 30, 2025.
  • Over the past year, IMCR TTM cash from operations has dropped by -$15.37 million (-66.04%).
  • IMCR TTM cash from operations is now -76.63% below its all-time high of $33.81 million, reached on June 30, 2025.

Performance

IMCR TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IMCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+786.4%-121.6%-66.0%
3Y3 Years+118.2%-144.5%+111.7%
5Y5 Years+119.3%-100.8%+444.7%

IMCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+118.2%-117.6%+72.8%-76.6%+111.7%
5Y5-Yearat high+118.2%-117.6%+90.2%-76.6%+105.4%
All-TimeAll-Timeat high+118.2%-117.6%+90.2%-76.6%+105.4%

IMCR Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$4.60M(-117.6%)
$7.90M(-76.6%)
Jun 2025
-
$26.19M(+5897.1%)
$33.81M(+8.7%)
Mar 2025
-
$436.70K(+103.1%)
$31.09M(+19.3%)
Dec 2024
$26.06M(+786.4%)
-$14.12M(-166.3%)
$26.07M(+12.0%)
Sep 2024
-
$21.30M(-9.3%)
$23.27M(+107.9%)
Jun 2024
-
$23.48M(+612.1%)
$11.19M(+191.2%)
Mar 2024
-
-$4.58M(+72.9%)
-$12.27M(-515.7%)
Dec 2023
$2.94M(+106.0%)
-$16.92M(-283.5%)
$2.95M(-89.4%)
Sep 2023
-
$9.22M(>+9900.0%)
$27.81M(-3.9%)
Jun 2023
-
$16.40K(-99.8%)
$28.94M(+69.8%)
Mar 2023
-
$10.63M(+33.9%)
$17.04M(+147.3%)
DateAnnualQuarterlyTTM
Dec 2022
-$49.21M(+65.6%)
$7.94M(-23.3%)
-$36.06M(+46.5%)
Sep 2022
-
$10.35M(+187.1%)
-$67.38M(+37.7%)
Jun 2022
-
-$11.88M(+72.0%)
-$108.23M(+24.4%)
Mar 2022
-
-$42.47M(-81.7%)
-$143.21M(-4.0%)
Dec 2021
-$143.11M(-71.4%)
-$23.37M(+23.4%)
-$137.68M(+5.3%)
Sep 2021
-
-$30.50M(+34.9%)
-$145.46M(-24.1%)
Jun 2021
-
-$46.86M(-26.9%)
-$117.25M(-66.6%)
Mar 2021
-
-$36.94M(-18.6%)
-$70.38M(-110.5%)
Dec 2020
-$83.47M(+38.1%)
-$31.15M(-1258.9%)
-$33.44M(-1358.9%)
Sep 2020
-
-$2.29M
-$2.29M
Dec 2019
-$134.92M(-539.5%)
-
-
Dec 2018
-$21.10M
-
-

FAQ

  • What is Immunocore Holdings plc annual cash from operations?
  • What is the all-time high annual cash from operations for Immunocore Holdings plc?
  • What is Immunocore Holdings plc annual cash from operations year-on-year change?
  • What is Immunocore Holdings plc quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Immunocore Holdings plc?
  • What is Immunocore Holdings plc quarterly cash from operations year-on-year change?
  • What is Immunocore Holdings plc TTM cash from operations?
  • What is the all-time high TTM cash from operations for Immunocore Holdings plc?
  • What is Immunocore Holdings plc TTM cash from operations year-on-year change?

What is Immunocore Holdings plc annual cash from operations?

The current annual cash from operations of IMCR is $26.06M

What is the all-time high annual cash from operations for Immunocore Holdings plc?

Immunocore Holdings plc all-time high annual cash from operations is $26.06M

What is Immunocore Holdings plc annual cash from operations year-on-year change?

Over the past year, IMCR annual cash from operations has changed by +$23.12M (+786.43%)

What is Immunocore Holdings plc quarterly cash from operations?

The current quarterly cash from operations of IMCR is -$4.60M

What is the all-time high quarterly cash from operations for Immunocore Holdings plc?

Immunocore Holdings plc all-time high quarterly cash from operations is $26.19M

What is Immunocore Holdings plc quarterly cash from operations year-on-year change?

Over the past year, IMCR quarterly cash from operations has changed by -$25.90M (-121.61%)

What is Immunocore Holdings plc TTM cash from operations?

The current TTM cash from operations of IMCR is $7.90M

What is the all-time high TTM cash from operations for Immunocore Holdings plc?

Immunocore Holdings plc all-time high TTM cash from operations is $33.81M

What is Immunocore Holdings plc TTM cash from operations year-on-year change?

Over the past year, IMCR TTM cash from operations has changed by -$15.37M (-66.04%)
On this page